deltatrials
Recruiting OBSERVATIONAL NCT06717594

PK/PD Relationship of CAZ/AVI and FOS in the Treatment of Patients With Infections Due to CRE (CAVIFOS)

PK/PD Relationship of CAZ/AVI and FOS in the Treatment of Patients With Infections Due to Carbapenem-resistant Enterobacterales (CRE)

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna

Conditions Antimicrobial Resistance (AMR) Gram Negative Infections
Updated 2 times since 2025 Last updated: Nov 26, 2025 Started: Dec 1, 2023 Primary completion: Apr 30, 2026 Completion: Apr 30, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Antimicrobial Resistance (AMR) and Gram Negative Infections and is currently actively recruiting participants. IRCCS Azienda Ospedaliero-Universitaria di Bologna leads this study, which shows 2 recorded versions since 2023 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Jan 2025 – ~Dec 2025 · 11 months · monthly snapshotRecruiting~Dec 2025 – present · 9 months · monthly snapshotRecruiting

Change History

2 versions recorded

  1. Dec 2025 — Present [monthly]

    Recruiting

  2. Jan 2025 — Dec 2025 [monthly]

    Recruiting

    First recorded

Dec 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna
Data source: IRCCS Azienda Ospedaliero-Universitaria di Bologna

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations